Tandem Capital Management Corp ADV Raises Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tandem Capital Management Corp ADV boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 28,210 shares of the company’s stock after buying an additional 118 shares during the period. GE HealthCare Technologies makes up approximately 1.2% of Tandem Capital Management Corp ADV’s investment portfolio, making the stock its 27th largest holding. Tandem Capital Management Corp ADV’s holdings in GE HealthCare Technologies were worth $2,205,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the stock. LGT Financial Advisors LLC raised its stake in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares during the period. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC raised its stake in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after buying an additional 168 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Price Performance

GEHC stock opened at $87.51 on Tuesday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies Inc. has a 1 year low of $72.61 and a 1 year high of $94.55. The firm has a market capitalization of $39.98 billion, a P/E ratio of 24.04, a P/E/G ratio of 2.92 and a beta of 1.14. The business’s 50-day moving average is $82.97 and its two-hundred day moving average is $85.09.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.